Other papers submitted by: Dr Jane Sullivan

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Jane Sullivan

Paper published by Dr Jane Sullivan:

Original Research

Noteworthy comment: Survival and best supportive care costs for patients with metastatic renal cell carcinoma (mRCC) after stopping therapy are poorly characterized yet an important aspect of patient care. This study examined survival and costs associated with BSC after 1 or 2 lines of mRCC therapy

Highly-accessed

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Henk HJ, Chen C, Benedict A, Sullivan J, Teitelbaum A

ClinicoEconomics and Outcomes Research 2013, 5:347-354

Published Date: 9 July 2013